Joe Biden's prostate cancer, marked by a high Gleason score and bone metastasis, is likely to be hormone-sensitive. Experts speak about treatment strategies and prognosis.

A study led by Cancer Center at Illinois (CCIL) member Jason Ridlon, associate professor of animal sciences in the College of ...

Pluvicto demonstrated positive results in patients with PSMA-positive metastatic hormone-sensitive prostate cancer.

As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a new study sheds ...

The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women receiving endocrine ...

Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2 ...

Dr. Alicia Morgans discussed complications associated with ADT in prostate cancer, and how men can still maintain quality of ...

A “breakthrough” new three-drug combination offers hope for women battling an aggressive form of breast cancer, potentially ...

New findings suggest that a PSA level of 0.2 ng/mL or greater can predict a poor prognosis and indicate a possible need for ...

Researchers evaluated current treatment patterns and clinical outcomes for patients with HER2-positive metastatic breast cancer.